Chronic Myelomonocytic Leukemia Active Not Recruiting Phase 2 Trials for Lenalidomide (DB00480)

Also known as: Chronic myelomonocytic leukaemia / Chronic myelomonocytic leukemia with failed remission / Leukemia, Myelomonocytic, Chronic

DBCOND0028572 (Chronic Myelomonocytic Leukemia)Active Not Recruiting2 IdentifierTitlePurposeDrugs
NCT01522976Azacitidine With or Without Lenalidomide or Vorinostat in Treating Patients With Higher-Risk Myelodysplastic Syndromes or Chronic Myelomonocytic LeukemiaTreatment
NCT00885508A Study of the Efficacy and Safety of Lenalidomide Combined to Escalating Doses of Chemotherapy in Intermediate-2-or High Risk Myelodysplastic Syndrome (MDS) and Acute Myeloid Leukemia (AML) With Del 5qTreatment